Filing Details
- Accession Number:
- 0001415889-22-012648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-16 19:36:34
- Reporting Period:
- 2022-12-14
- Accepted Time:
- 2022-12-16 19:36:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1302443 | E Rick Winningham | C/O Theravance Biopharma Us, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-12-13 | 9,000 | $0.00 | 1,400,797 | No | 5 | G | Direct | |
| Ordinary Shares | Disposition | 2022-12-14 | 50,000 | $11.19 | 1,350,797 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 92,567 | Indirect | By Trust |
Footnotes
- Bona Fide Gift. No compensation was given to the donor for the gifting of shares.
- This transaction was executed in multiple trades at prices from $11.17 to $11.235 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
